CD160 Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule.
Synonyms
NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160
Gene ID
11126
Swiss Prot
O95971
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
81-159/181
Target
CD160
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human CD160
Applications
WB, FCM, IF (IHC-P)
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
11126
Predicted Cross Reactivity
Mouse, Rat, Dog
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030161 100 µg
Recombinant EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) VP40 / Matrix protein VP40 Protein (His & MBP Tag)
Sign In for Pricing
View Details 
35731111 3x 1.0 µg
ORC4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 